Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical methotrexate dose-response and safety study for fingernail psoriasis
ISRCTN62739763Phase 3Completed
- Sponsor
- MediQuest Therapeutics
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3 trial of methotrexate in nail psoriasis (3 arms), sponsored by MediQuest Therapeutics. Primary endpoints: Improvement in appearance of the target fingernail and Safety and adverse events. Started Oct 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on ISRCTN62739763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62739763.